Here you will find products from Military Health System organizations. You can choose to look at certain types of products using the left hand navigation box or find products by keyword using the search box below.
If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.
We found - potentially matching ""
Advanced Search Options
This is the BCF-ECF list from the current P&T minutes in spread sheet form
A briefing for Commanders to utilize in implementing DHA-PM
A briefing that provides an overview of the CQM Top 10 Key Changes by volume
An infographic providing an overview of DHA-PM 6025.13
An infographic providing an outline of the top ten key changes in DHA-PM 6025.13
This is the Non-formulary list from the current P&T minutes in spread sheet form
This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (i), establishes the Defense Health Agency’s (DHA) procedures to establish required standards for: a. Military Medical Treatment Facilities (MTFs) and primary care clinics for adult, child and adolescent, health behavior, behavioral medicine, and behavioral health services in primary care. b. Behavioral Health Consultants (BHCs). c. Behavioral Health Care Facilitators (BHCFs). d. External Behavioral Health Consultants (EBHCs). e. Primary Care Clinic Leaders.
This DHA document discusses the importance of Quality-of-Life Measures for People with Chronic Conditions
Recommended Content:
To assess the impact of plan changing in TRICARE, we examined data from the first quarter of the 2019 Health Care Survey of Department of Defense Beneficiaries (HCSDB), which was fielded during open enrollment.
This DHA document examines how access to care and satisfaction with one’s health plan, care, and doctors affect whether Military Health System beneficiaries change health plans.
Vaccine information sheet published by the Centers for Disease Control and Prevention about the Adenovirus
Uniform Formulary Beneficiary Advisory Panel Meeting Agenda for January 8, 2020
Background Information for the Uniform Formulary Beneficiary Advisory Panel
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.